What GLP-1 drugs mean for medtech
Clarivate
MAY 1, 2024
GLP-1s will offer an attractive option to patients hesitant to undergo an invasive surgical procedure, and manufacturers like Medtronic and Johnson & Johnson anticipate a temporary dip in surgery volumes. Device-based treatments for comorbidities associated with obesity will also see an impact.
Let's personalize your content